Metabolic profiling of glioblastoma and identification of G0S2 as a metabolic target
{{output}}
Introduction: Metabolic reprogramming is a hallmark of cancer, yet its role in glioma remains poorly understood. Gliomas are characterized by a highly immunosuppressive tumor microenvironment (TME) and poor prognosis. This study ... ...
